Vaccine availability in the US: Problems and solutions

Nature Immunology

Volumn 5, Issue 12, 2004, Pages 1195-1198

  Poland, Gregory A ^a   Marcuse, Edgar K ^b  

^a Mayo Vaccine Research Group   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; DIPHTHERIA TETANUS TOXOID; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; VACCINE;

BIOLOGICAL WARFARE; DRUG COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; INFLUENZA; PRIORITY JOURNAL; REVIEW; UNITED STATES; ARTICLE; COMMERCIAL PHENOMENA; ECONOMICS; LEGAL ASPECT; PROBLEM SOLVING; PUBLIC HEALTH; STANDARD; VACCINATION;

COMMERCE; HUMANS; INFLUENZA VACCINES; PROBLEM SOLVING; PUBLIC HEALTH; UNITED STATES; VACCINATION;

EID: 16544362453     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1204-1195     Document Type: Review

References (9)

1. Committee on Immunization Finance Policies and Practices, Division of Health Care Services and Division of Health Promotion and Disease Prevention, Institute of Medicine. Calling the shots: immunization finance policies and practices (National Academy Press, Washington, DC, 2000).
2. Vaccines - endangered species? Nat. Immunol. 3, 695 (2002).
3. Batson, A., Glass, S. & Seiguer, E. The vaccine book (eds. Bloom, B.R. & Lamber, P.H.) 345-370 (Academic Press, San Diego, 2003).
4. Steffy, C.A.P. & Rosin, L. BioProcess International 2, 48-57 (2004).
5. Committee on the Evaluation of Vaccine Purchase Financing in the United States, Board on Health Care Services, Institute of Medicine of the National Academies. Financing vaccines in the 21st century: assuring access and availability (National Academy Press, Washington, DC, 2003).
6. Santoli, J.M. et al. J. Am. Med. Assn. 290, 3122-3128 (2003).
7. Pauley, M., Robinson, C.A., Sepe, S.J., Sing, M. & William, M.K. (eds). Supplying vaccine: an economic analysis of critical issues (IOS Press, Washington, DC, 1996).
8. Institute of Medicine of the National Academy of Science. Vaccines for the 21st century: A tool for decisionmaking (eds. Stratton, K.R., Durch, J.S. & Lawrence, R.S.) (National Academy Press, Washington, DC, 2000).
9. Wilson, C.B. & Marcuse, E.K. Vaccine safety - vaccine benefits: science and the public's perception. Nat. Rev. Immunol. 1, 160-165 (2001).